{
  "ptid_time": "141_S_4160_2012-10-20",
  "img_path": "/data/qiuhui/data/adni/images/141_S_4160/2012-10-20/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 72,627 mm³, 88.6% above the reference mean. With a Z-score of 2.12 (98.3th percentile), this represents significant enlargement; hippocampal volume measures 6,803 mm³, 10.0% below the reference mean. With a Z-score of -0.98 (16.5th percentile), this represents normal volume ; whole brain volume measures 1,045,270 mm³, 3.2% below the reference mean. With a Z-score of -0.41 (34.1th percentile), this represents normal volume ; entorhinal cortex volume measures 2,584 mm³, 37.0% below the reference mean. With a Z-score of -2.51 (0.6th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,552 mm³, 22.8% below the reference mean. With a Z-score of -1.94 (2.6th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 20,566 mm³, 3.6% below the reference mean. With a Z-score of -0.33 (37.2th percentile), this represents normal volume . ",
  "text_data": "Age is 75.1 years. Gender is Male. Education: 12 years. MMSE: 29.0. MoCA: 17.0. Logical Memory: 5.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant ventricular enlargement (consistent with atrophy) and marked atrophy in the entorhinal cortex and fusiform gyrus—key regions affected in Alzheimer’s disease. Despite normal hippocampal volume, the MoCA score of 17 (below the typical cutoff of 26 for normal cognition) strongly suggests cognitive impairment. The MMSE of 29 is less sensitive but does not rule out MCI or early dementia.  \n\n**Diagnosis:** **MCI (likely due to Alzheimer’s pathology)**  \n**Confidence:** **Medium** (High for cognitive impairment, but MoCA/MMSE discrepancy and lack of APOE4 leave some uncertainty about etiology).  \n\n*Note:* The entorhinal/fusiform atrophy and low MoCA are highly suggestive of neurodegenerative decline, but the preserved hippocampus and MMSE raise the possibility of non-AD contributors (e.g., vascular, Lewy body). CSF biomarkers or amyloid PET could clarify.",
  "timestamp": "2025-07-26T17:02:15.063694"
}